Bankrupt drugmaker Endo International will pay up to $465 million to settle the federal government's law enforcement, tax, and healthcare cost claims, the DOJ said. Read: https://t.co/mTQLlvlfpg Subscribe: https://t.co/y8QuCqnNgg https://t.co/IhX77ZFO1U
Endo International, a pharmaceutical company whose U.S. headquarters is in Malvern, agreed to pay the government up to $465 million to settle civil and criminal investigations into the sales and marketing of an opioid drug, federal authorities said. https://t.co/wC5aMbtnr2
Drugmaker Endo reaches $465 mln bankruptcy settlement with US https://t.co/tdzajMUN3g https://t.co/iz1PJSeem4

Endo International, a pharmaceutical company, has agreed to pay as much as $465 million to settle criminal and civil investigations related to the sale and marketing of an opioid drug. The settlement with the US government includes relief payments and resolves law enforcement, tax, and healthcare cost claims, removing obstacles to the company's bankruptcy plan.


